Does Growth Hormone Drug Slow Alzheimer's Disease?

A new study shows that a drug that increases the release of growth hormone failed to slow the rate of progression of Alzheimer's disease in humans.

How Red Wine Might Prevent and Treat Alzheimer's Disease

Red wine and the treatment of alzheimer's disease

Red wine has many health benefits. We know it is good for cardiovascular health. Alzheimer's disease researchers at UCLA have now discovered how red wine might prevent and provide treatment for existing Alzheimer's disease. David Teplow, a UCLA professor of neurology, and colleagues discuss their findings in the Nov.

Examining Early, Inherited Form Of Alzheimer's

The adult children of people diagnosed with inherited Alzheimer's disease are the focus of a new study to better understand the biology of the disease.

Gardening Reduces Stress For Alzheimer's Caregivers

This November, during National Alzheimer's Disease Awareness Month and National Family Caregivers Month and just in time for holiday gift giving, the Alzheimer’s Association and Meredith Publications are helping to reduce Alzheimer's caregivers’ stress and beautify gardens nationwide with the Alzheimer Awareness Perennial Garden.

Ginkgo Biloba Does Not Prevent Alzheimer's Disease

Ginkgo Biloba is the latest supplement shown in randomized clinical trials to be of no benefit in the prevention of dementia or Alzheimer’s disease.

Kentucky Proclaims November Alzheimer's Awareness Month

To bring awareness about a devastating disease that affects thousands of Kentuckians and their families, Gov. Steve Beshear has proclaimed November Alzheimer's Disease Awareness Month in Kentucky.

Axona: New Approach For Managing Alzheimer's Disease

Accera will launch Axona in the United States for Alzheimer's disease (AD) in the first quarter of 2009.

Alzheimer's Gene Slows Brain's Ability To Export Toxic Protein

The only known genetic risk factor for Alzheimer's disease slows down the brain's ability to export a toxic protein known as amyloid-beta that is central to the damage the disease causes.

Research find key contributor to Alzheimer's disease

The paper, An NF-kB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer's disease and in stressed human brain cells, will be published in the November 14, 2008 issue of The Journal of Biological Chemistry.

Caring For Loved Ones With Alzheimer's Dementia

Today, more than five million Americans have Alzheimer's disease, many of whom are in the mild to moderate stages of the disease.